There’s always something happening in the market. Here’s what we’re watching right now:
P.S. For more stocks making moves, check out our Zen Ratings Upgrades & Downgrades screener.
A note from our sponsors...
Attention Investors: The 10 Best stocks for 2026-yours FREE Today, we are inviting you to take a free peek at MarketBeat's proprietary, exclusive and up-to-the-minute list of the 10 Best Stocks to Buy in 2026. Many of these companies might appear to be nothing special at first glance. Others might be names you have heard of before and decided to pass on, but financials don't lie. Now is the time to take a look. It's yours absolutely FREE. Get Your Copy of "10 Best Stocks to Own in 2026" Here.🔥 HOT: Pharma company AbbVie (NYSE: ABBV) is blazing right now, with its stock gaining 13% in the past 3 months, culminating in a new all-time high late last week. The real firestarter? Recent Phase II trial results showing outpatient viability for its drug Epkinly, which signals not only a major expansion in AbbVie’s oncology arsenal but also the potential for serious revenue growth. AbbVie sports a Zen Rating of B, landing it in a tier of stocks that have historically delivered 19.88% annual returns. Looking at its Component Grades, ABBV earns a coveted A for Safety, with above-average grades for Sentiment, Financials, and from our proprietary AI factor. Sentiment and Financials scores. With a slew of recent drug approvals in Canada, this pharma company is looking more and more like a player with continued portfolio potential.
🥶 NOT: Once the poster child of tech market heat, Tesla (NASDAQ: TSLA), has been experiencing a fair bit of choppiness in recent months. (Our Zen Investor Editor-In-Chief, Steve Reitmeister, even issued a Sell alert on it). Despite the hype around Elon Musk’s blockbuster $1 trillion pay package (which certainly grabs headlines and hints at bold future ambitions), the stock’s actual story is thin on substance. The top bullish news catalyst is analyst optimism and a new price target, yet the fundamentals continue to drag; price movement has been tepid compared to the wild swings of old, and there’s no earnings or revenue pop to hang your hat on. While the stock is up roughly 5% in the past week, its fundamentals look far from supercharged. Tesla sports a glum Zen Rating of F (Strong Sell), languishing in the lowest tier of its sector with especially dreadful marks in Value (D) and Growth (D). Every other Component Grade—Momentum, Sentiment, Safety, Financials, AI — is a ho-hum C, offering little relief for the bulls.
🔥 HOT: Micron Technology (NASDAQ: MU) is bringing heat to the semiconductor scene with an impressive rally — the stock has gained over 40% YTD, and recently vaulted above all short- and long-term moving averages. Sentiment is solid (here’s why that matters), with glowing analyst picks, high-profile portfolio manager shoutouts, and business media raving about Micron's resurgence thanks to strong DRAM revenue growth and favorable pricing. But the numbers are what truly sizzle here. Micron scores a stellar Zen Rating of A (Strong Buy), ranking in the top 5% of stocks we track. Despite a smattering of Component Grades of C for areas like Safety and Growth, the stock earns an excellent A rating for Sentiment and an above-average grade for Financials. Not only is Micron pulling ahead on the charts, but its story is woven into the very fabric of AI’s explosive growth. Price action appears to confirm the vibe, with the stock outpacing its sector.
A note from our sponsors...
Valuation Up 5,000%. Shares Now $0.85 - Still Early? RAD Intel has emerged as a critical player in the AI infrastructure powering digital advertising. It's already working with Fortune 1000 clients, fueling their marketing performance through a proprietary AI decision layer that delivers results-not hype. Backed by Adobe, Fidelity Ventures, and insiders from Google, Meta, and Amazon, RAD Intel has raised over $60 million and grown its valuation over 5,000% in under four years. The share price recently increased to $0.85, reflecting the company's momentum-but there's still limited allocation available. Over 14,000 investors have already moved. If you're still watching from the sidelines, now may be the time to act. View the investor brief and lock in $0.85 shares while the current allocation remains open. *This valuation has been set by RAD Intel. DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A+ offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radintel.ai.🥶 NOT: Despite being a market legend, JPMorgan Chase (NYSE: JPM) is struggling to stoke any real heat following a recent Zen Ratings downgrade (more on that in a sec). Why? A weak jobs report and a sector-wide retreat in financials have created bearish sentiment that overshadows upside from strategic leadership shuffles or new digital payment projects. JPM’s price, now at $294.38, has slipped below its 10-day average and only hovers just above the 200-day mark — tepid at best. While the stock price hasn’t dropped precipitously, its Zen Rating has — not only is JPM in an industry that’s currently D rated (here’s how to use our Industry Ratings), the stock itself also earns a D (Sell) rating. The Component Grades are also dismal, with a D grade for Value and a crushing F grade for Growth that can’t make up for solid Bs in Sentiment and Momentum. Macro weakness and the lack of any recent earnings or revenue fireworks mean this stalwart is better suited to a wait-and-see approach.
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.